folder

Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation

Authors

  • B. Lamarca
  • J. Speed
  • L.F. Ray
  • K. Cockrell
  • G. Wallukat
  • R. Dechend
  • J. Granger

Journal

  • International Journal of Interferon, Cytokine and Mediator Research

Citation

  • Int J Infereron Cytokine Mediator Res 2011 (3): 65-70

Abstract

  • BACKGROUND: Increases in interleukin 6 (IL-6) and agonistic autoantibodies to the angiotensin II type 1 receptor (AT1-AA) are proposed to be important links between placental ischemia and hypertension in preeclampsia. METHODS: The purpose of this study was to determine whether IL-6 (5 ng/day), infused into normal pregnant (NP) rats, increased mean arterial pressure (MAP) and AT1-AA. MAP was analyzed in the presence and absence of an angiotensin type 1 receptor (AT1R) antagonist, losartan, L. RESULTS: MAP and AT1-AA increased from 102 ± 2 to 118 ± 4 mmHg and 0.7 ± 0.3 NP to 14.1 ± 1.4 chronotropic units with chronic IL-6 infusion. MAP responses to IL-6 were abolished in losartan pretreated rats (85 ± 4 in NP + L vs 85 ± 3 mmHg in IL-6 + L). CONCLUSION: These data indicate that IL-6 stimulates AT1-AA and that activation of the AT1R mediates IL-6 induced hypertension during pregnancy.


DOI

doi:10.2147/IJICMR.S22329